Kintsugi

Kintsugi is an AI company that detects signs of depression and anxiety from voice to support behavioral health screening. The product is positioned around self-guided support, triage, measurement, or therapy documentation rather than crisis care, and professional clinical care remains essential for any acute mental health need. Buyers should confirm clinical evidence depth, regulatory scope where it applies, member support coverage, and integration with existing behavioral programs before committing.

Buyers usually compare Kintsugi for voice biomarkers for mental health screening, with health plans and provider programs as the core audience. The trade-off to keep in mind: supports screening, not crisis or diagnosis. Pricing is sales-led and scoped per buyer rather than posted publicly. A focused pilot, scoped to one workflow, is usually the cleanest way to test fit.